ZEV Biotech
Solution Type
Microbial Management, Antimicrobial Stewardship, Diagnostics
Pathogens Addressed
Bacteria, Fungi
Sectors Served
Human Health
Overview
ZEV Biotech is a Brussels-based biotechnology company developing phage-derived antimicrobial proteins , specifically endolysins , as novel therapeutics against drug-resistant bacterial infections. Endolysins are enzymes produced by bacteriophages that lyse bacterial cell walls with high specificity, offering a targeted, resistance-resilient alternative to broad-spectrum antibiotics for treating serious infections caused by multidrug-resistant Gram-positive and Gram-negative pathogens.
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
